Creatine affects in vitro electrophysiological maturation of neuroblasts and protects them from oxidative stress

Journal of Neuroscience Research

Volumn 90, Issue 2, 2012, Pages 435-446

  Sartini, Stefano ^a   Sestili, Piero ^a   Colombo, Evelin ^a   Martinelli, Chiara ^a   Bartolini, Fanny ^a   Ciuffoli, Stefano ^a   Lattanzi, Davide ^a   Sisti, Davide ^a   Cuppini, Riccardo ^a  

^a UNIVERSITY OF URBINO   (Italy)

Author keywords

Creatine; Differentiation; Ion currents; Neuron; Oxidative stress

Indexed keywords

CREATINE; RADICAL; THIOL DERIVATIVE; TROLOX C;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN DEVELOPMENT; CELL MATURATION; CELL STRUCTURE; CELL VIABILITY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOSOL; DEPOLARIZATION; DIET SUPPLEMENTATION; ELECTROPHYSIOLOGY; EMBRYO; IN VITRO STUDY; NERVE CELL DIFFERENTIATION; NERVE CELL EXCITABILITY; NERVOUS SYSTEM DEVELOPMENT; NEURITE; NEUROBLAST; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SODIUM CURRENT; SPIKE;

ANIMALS; ANTIOXIDANTS; CELL DIFFERENTIATION; CELL ENLARGEMENT; CELLS, CULTURED; CHICK EMBRYO; CREATINE; ELECTROPHYSIOLOGICAL PHENOMENA; NEURAL STEM CELLS; OXIDATIVE STRESS; SPINAL CORD;

EID: 83155182373     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22762     Document Type: Article

References (52)

1. Alfieri RR, Bonelli MA, Cavazzoni A, Brigotti M, Fumarola C, Sestili P, Mozzoni P, De Palma G, Mutti A, Carnicelli D, Vacondio F, Silva C, Borghetti AF, Wheeler KP, Petronini PG. 2006. Creatine as a compatible osmolyte in muscle cells exposed to hypertonic stress. J Physiol 576: 391-401.
2. Almeida LS, Salomons GS, Hogenboom F, Jakobs C, Schoffelmeer ANM. 2006. Exocytotic release of creatine in rat brain. Synapse 60: 118-123.
3. Andres RH, Ducray AD, Huber AW, Pérez-Bouza A, Krebs SH, Schlattner U, Seiler RW, Wallimann T, Widmer HR. 2005. Effects of creatine treatment on survival and differentiation of GABA-ergic neurons in cultured striatal tissue. J Neurochem 95: 33-45.
4. Battini R, Alessandri G, Leuzzi V, Moro F, Tosetti M, Bianchi MC, Cioni G. 2006. Arginine glycineaminotransferase (AGAT) deficiency in a newborn: early treatment can prevent phenotypic expression of the disease. J Pediatr 148: 828-830.
5. Béard E, Braissant O. 2010. Synthesis and transport of creatine in the CNS: importance for cerebral functions. J Neurochem 115: 297-313.
6. Biella G, Di Febo F, Goffredo D, Moiana A, Taglietti V, Conti L, Cattaneo E, Toselli M. 2007. Differenziating embryonic stem-derived neural stem cells show a maturation-dependent pattern of voltage-gated sodium current expression and graded action potentials. Neuroscience 149: 38-52.
7. Braissant O, Henry H. 2008. AGAT, GAMT and SLC6A8 distribution in the central nervous system, in relation to creatine deficiency syndromes: a review. J Inher Metab Dis 31: 230-239.
8. Braissant O, Henry H, Villard AM, Zurich MG, Loup M, Eilers B, Parlascino G, Matter E, Boulat O, Honegger P, Bachmann C. 2002. Ammonium-induced impairment of axonal growth is prevented through glial creatine. J Neurosci 15: 9810-9820.
9. Braissant O, Bachmann C, Henry H. 2007. Expression and function of AGAT, GAMT and CT1 in the mammalian brain. Subcell Biochem 46: 67-81.
10. Cantoni O, Sestili P, Guidarelli A, Cattabeni F. 1994. Development and characterization of hydrogen peroxide-resistant Chinese hamster ovary (CHO) cell variants-II. Relationships between non-protein sulfhydryl levels and the induction/stability of the oxidant-resistant phenotype. Biochem Pharmacol 47: 1258-1261.
11. Cornelissen VA, Defoor JG, Stevens A, Schepers D, Hespel P, Decramer M, Mortelmans L, Dobbels F, Vanhaecke J, Fagard RH, Vanhees L. 2010. Effect of creatine supplementation as a potential adjuvant therapy to exercise training in cardiac patients: a randomized controlled trial. Clin Rehabil 24: 988-999.
12. De Deyn PP, MacDonald RL. 1990. Guanidino compounds that are increased in cerebrospinal fluid and brain of uremic patients inhibit GABA and glycine responses on mouse neurons in cell culture. Ann Neurol 28: 627-33.
13. Ducray AD, Schlappi JA, Qualls R, Andres RH, Seiler RW, Schlattner U, Wallimann T, Widmer HR. 2007. Creatine treatment promotes differentiation of GABA-ergic neuronal precursors in cultured fetal rat spinal cord. J Neurosci Res 85: 1863-1875.
14. Ferriero DM. 2001. Oxidant mechanisms in neonatal hypoxia-ischemia. Dev Neurosci 23: 198-202.
15. Ghiso J, Tomidokoro J, Revesz T, Frangione B, Rostagno A. 2010. Cerebral amyloid angiopathy and Alzheimer's disease. Hirosaki Igaku 61: s11-s124.
16. Giordano G, Pizzurro D, VandeMark K, Guizzetti M, Costa LG. 2009. Manganese inhibits the ability of astrocytes to promote neuronal differentiation. Toxicol Appl Pharmacol 240: 226-235.
17. Hardingham GE, Lipton SA. 2010. Regulation of neuronal oxidative and nitrosative stress by endogenous protective pathways and by disease processes. Antioxid Redox Signal (in press).
18. Ireland Z, Russell AP, Wallimann T, Walker DW, Snow R. 2009. Developmental changes in the expression of creatine synthesizing enzymes and creatine transporter in a precocial rodent, the spiny mouse. BMC Dev Biol 9: 39.
19. Khan JY, Black SM. 2003. Developmental changes in murine brain antioxidant enzymes. Pediatr Res 54: 77-82.
20. Klivenyi P, Ferrante RJ, Matthews RT, Bogdanov MB, Klein AM, Andreassen OA, Mueller G, Wermer M, Kaddurah-Daouk R, Beal MF. 1999. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat Med 5: 347-350.
21. Koga Y, Takahashi H, Oikawa D, Tachibana T, Denbow DM, Furuse M. 2005. Brain creatine functions to attenuate acute stress responses through GABAnergic system in chicks. Neuroscience 132: 65-71.
22. 1H magnetic resonance spectroscopy. Magn Reson Med 48: 949-958.
23. Kuhn TB. 2003. Growing and working with spinal motor neurons. Methods Cell Biol 71: 67-87.
24. Lawler JM, Barnes WS, Wu G, Song W, Demaree S. 2002. Direct antioxidant properties of creatine. Biochem Biophys Res Commun 290: 47-52.
25. Li Z, Okamoto KI, Hayashi Y, Sheng M. 2004. The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 119: 873-887.
26. Malcon C, Kaddurah-Daouk R, Beal MF. 2000. Neuroprotective effects of creatine administration against NMDA and malonate toxicity. Brain Res 860: 195-198.
27. Matthews RT, Yang L, Jenkins BG, Ferrante RJ, Rosen BR, Kaddurah-Daouk R, Beal MF. 1998. Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease. J Neurosci 18: 156-163.
28. Matthews RT, Ferrante RJ, Klivenyi P, Yang L, Klein AM, Mueller G, Kaddurah-Daouk R, Beal MF. 1999. Creatine and cyclocreatine attenuate MPTP neurotoxicity. Exp Neurol 157: 142-149.
29. Mcquillen PS, Ferriero DM. 2004. Selective vulnerability in the developing central nervous system. Pediatr Neurol 30: 227-235.
30. Meijering E, Jacob M, Sarria J-CF, Steiner P, Hirling H, Unser M. 2004. Design and validation of a tool for neurite tracing and analysis in fluorescence microscopy images. Cytometry 58: 167-176.
31. Mierlak D, Farb DH. 1988. Modulation of neurotransmitter receptor desensitization: chlordiazepoxide stimulates fading of the GABA response. J Neurosci 8: 814-820.
32. Miller TJ, Hanson RD, Yancey PH. 2000. Developmental changes in organic osmolytes in prenatal and postnatal rat tissues. Comp Biochem Physiol A Mol Integr Physiol 125: 45-56.
33. Morley JE, Argiles JM, Evans WJ, Bhasin S, Cella D, Deutz NE, Doehner W, Fearon KC, Ferrucci L, Hellerstein MK, Kalantar-Zadeh K, Lochs H, Macdonald N, Mulligan K, Muscaritoli M, Ponikowski P, Posthauer ME, Rossi Fanelli F, Schambelan M, Schols AM, Schuster MW, Anker SD. 2010. Nutritional recommendations for the management of sarcopenia. J Am Med Dir Assoc 11: 391-396.
34. O'brien JR, Fischbach DG. 1986. Exitatory synaptic transmission between interneurons and motoneurons in chick spinal chord cell cultures. J Neurosci 6: 3284-3289.
35. O'Gorman E, Beutner G, Wallimann T, Brdiczka, D. 1996. Differential effects of creatine depletion on the regulation of enzyme activities and on creatine-stimulated mitochondrial respiration in skeletal muscle, heart, and brain. Biochim Biophys Acta 1276: 161-170.
36. Pan F, Beam KG. 1999. The absence of resurgent sodium current in mouse spinal neurons. Brain Res 849: 162-168.
37. Represa A, Ben-Ari J. 2005. Trophic action of GABA on neuronal development. Trends Neurosci 28: 278-283.
38. Royes LF, Fighera MR, Furian AF, Oliveira MS, da Silva LG, Malfatti CR, Schneider PH, Braga AL, Wajner M, Mello CF. 2003. Creatine protects against the convulsive behavior and lactate production elicited by the intrastriatal injection of methylmalonate. Neuroscience 118: 1079-1090.
39. Royes LF, Fighera MR, Furian AF, Oliveira MS, Myskiw Jde C, Fiorenza NG, Petry JC, Coelho RC, Mello CF. 2006. Effectiveness of creatine monohydrate on seizures and oxidative damage induced by methylmalonate. Pharmacol Biochem Behav 83: 136-144.
40. Schulze A. 2003. Creatine deficiency syndrome. Mol Cell Biochem 244: 143-150.
41. Schulze A, Battini R. 2007. Pre-symptomatic treatment of creatine biosynthesis defects. Subcell Biochem 46: 167-181.
42. Schulze A, Hoffmann GF, Bachert P, Kirsch S, Salomons GS, Verhoeven NM, Mayatepek E. 2006. Presymptomatic treatment of neonatal guanidinoacetate methyltransferase deficiency. Neurology 67: 719-721.
43. Sestili P, Martinelli C, Bravi G, Piccoli G, Curci R, Battistelli M, Falcieri E, Agostini D, Gioacchini AM, Stocchi V. 2006. Creatine supplementation affords cytoprotection in oxidatively injured cultured mammalian cells via direct antioxidant activity. Free Radic Biol Med 40: 837-849.
44. Sestili P, Barbieri E, Martinelli C, Battistelli M, Guescini M, Vallorani L, Casadei L, D'Emilio A, Falcieri E, Piccoli G, Agostini D, Annibalini G, Paolillo M, Gioacchini AM, Stocchi V. 2009. Creatine supplementation prevents the inhibition of myogenic differentiation in oxidatively injured C2C12 murine myoblasts. Mol Nutr Food Res 53: 1187-1204.
45. Siddappa AJ, Rao RB, Wobken JD, Leibold EA, Connor JR, Georgieff MK. 2002. Developmental changes in the expression of iron regulatory proteins and iron transport proteins in the perinatal rat brain. J Neurosci Res 68: 761-775.
46. Smith DW, Friedmann T. 2004. Discrepant effects of culture conditions on survival and function of dopaminergic neurons. Neuroreport 15: 1025-1028.
47. Stöckler S, Schutz PW, Salomons GS. 2007. Cerebral creatine deficiency syndromes: clinical aspects, treatment and pathophysiology. Subcell Biochem 46: 149-166.
48. Taupin PA. 2010. Dual activity of ROS and oxidative stress on adult neurogenesis and Alzheimer's disease. CNS Agents Med Chem 10: 16-21.
49. Walsh B, Tonkonogi M, Soderlund K, Hultman E, Saks V, Sahlin K. 2001. The role of phosphorylcreatine and creatine in the regulation of mitochondrial respiration in human skeletal muscle. J Physiol 537: 971-978.
50. Weis SN, Schunck RV, Pettenuzzo LF, Krolow R, Matté C, Manfredini V, Peralba MD, Vargas CR, Dalmaz C, Wyse AT, Netto CA. 2011. Early biochemical effects after unilateral hypoxia-ischemia in the immature rat brain. Int J Dev Neurosci (in press).
51. Wyss M, Kaddurah-Daouk R. 2000. Creatine and creatinine metabolism. Physiol Rev 80: 1107-1213.
52. Wyss M, Braissant O, Pischel I, Salomons GS, Schulze A, Stockler S, Wallimann T. 2007. Creatine and creatine kinase in health and disease-a bright future ahead? Subcell Biochem 80: 309-334.